Cargando…
Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
Diabetic retinopathy (DR) is the major cause of visual impairment and blindness in the working-age population. Conventional management for nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema (DME) is derived from the findings of the Early Treatment Diabetic Retinopathy Study...
Autores principales: | Arabi, Amir, Tadayoni, Ramin, Ahmadieh, Hamid, Shahraki, Toktam, Nikkhah, Homayoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850856/ https://www.ncbi.nlm.nih.gov/pubmed/35194501 http://dx.doi.org/10.18502/jovr.v17i1.10175 |
Ejemplares similares
-
Effects of Oral Vitamin D Supplement Therapy on Clinical Outcomes of Intravitreal Bevacizumab in Diabetic Macular Edema
por: Karimi, Saeed, et al.
Publicado: (2021) -
Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018) -
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020) -
Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema
por: Karimi, Saeed, et al.
Publicado: (2022) -
Macular Edema: Drying Is Not Repairing
por: Tadayoni, Ramin
Publicado: (2013)